Picture of Cohance Lifesciences logo

COHANCE — Cohance Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: India's Suven Pharmaceuticals Ltd Sept-Quarter Consol Net Profit Rises

Nov 9 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * INDIA'S SUVEN PHARMACEUTICALS LTD SEPT-QUARTER CONSOL NET
PROFIT
795.6 MILLION RUPEES VERSUS 720.6 MILLION RUPEES YEAR AGO
    * SUVEN PHARMACEUTICALS LTD SEPT-QUARTER CONSOL REVENUE FROM
OPERATIONS 2.31 BILLION RUPEES VERSUS 2.78 BILLION RUPEES YEAR
AGO

Source text for Eikon:  ID: 
Further company coverage:  SUVH.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cohance Lifesciences

See all news